S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea · Delayed Price · Currency is KRW 17,310
+360 (2.12%)
At close: Jul 27, 2026
S.Biomedics Market Cap
S.Biomedics has a market cap or net worth of 214.39 billion as of July 28, 2026. Its market cap has decreased by -12.46% in one year.
Market Cap
214.39B
Enterprise Value
224.90B
Revenue
16.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
17,310.00
ChartMarket Cap Chart
Since May 4, 2023, S.Biomedics's market cap has increased from 206.56B to 214.39B, an increase of 3.79%. That is a compound annual growth rate of 1.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 214.39B | -52.72% |
| Dec 30, 2025 | 453.47B | 123.16% |
| Dec 30, 2024 | 203.20B | 55.86% |
| Dec 28, 2023 | 130.38B | -36.88% |
| May 4, 2023 | 206.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IntoCell | 296.68B |
| HansBiomed | 280.95B |
| IMBiologics | 253.15B |
| Kangstem Biotech | 198.92B |
| curacle co.,ltd. | 191.31B |
| Genome & Company | 168.80B |
| NIBEC | 161.76B |
| Ensol Biosciences | 161.33B |